Vimarsana
Biggest News Aggregation in the World

Page 2 - Clinical Update News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical Update. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Update Today - Breaking & Trending Today

Breaking barriers in healthcare - the event you can't afford to miss - Vimarsana News

Breaking barriers in healthcare - the event you can't afford to miss

MIMS Learning editor Pat Anderson talks to GPonline about the forthcoming MIMS Learning Live event on 9 June 2023 at the Business Design Centre, London.

Learn, earn CPD and network with peers at MIMS Learning Live London - Vimarsana News

Learn, earn CPD and network with peers at MIMS Learning Live London

Registration is now open for MIMS Learning Live London on 9 June at the Business Design Centre. Registration is FREE. Earn up to 5.25 CPD in this 5-stream event, covering nine clinical topics, helping you meet your learning objectives for appraisal.

EQS-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics to Present a Clinical Update on its Novel Oral Small Molecule Varoglutamstat at Clinical Trials on Alzheimer's Disease Conference (CTAD) - Vimarsana News

EQS-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics to Present a Clinical Update on its Novel Oral Small Molecule Varoglutamstat at Clinical Trials on Alzheimer's Disease Conference (CTAD)

EQS-News: Vivoryon Therapeutics N.V. / Key word(s): Conference Vivoryon Therapeutics N.V.: Vivoryon Therapeutics to Present a Clinical Update on its Novel Oral Small Molecule Varoglutamstat

Aptose Clinical Data to be Presented at the 2022 ASH Annual - Vimarsana News

Aptose Clinical Data to be Presented at the 2022 ASH Annual

Data for Tuspetinib (HM43239) and Luxeptinib Accepted for Poster Presentation...

Tiziana Announces Availability of March 14 KOL Event - Vimarsana News

Tiziana Announces Availability of March 14 KOL Event

NEW YORK, March 15, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company enabling...